VIREAD 300MG

VIREAD 300MG

24.60 USD ($)/Bottle

Product Details:

  • Drug Type Other Types
  • Ingredients Tenofovir disoproxil fumarate (300mg)
  • Physical Form Tablets
  • Function Anti-Cancer
  • Recommended For Suitable for all
  • Dosage 300MG
  • Dosage Guidelines WHO
  • Supply Ability : 5000 Bottle Per Week
  • Click to view more
X

Price And Quantity

  • 24.60 USD ($)/Bottle
  • 50 Bottle

Product Specifications

  • Tenofovir disoproxil fumarate (300mg)
  • Store in a cool and dry place, Protect from light. Store in the original package . Avoid excessive heat and humidity.
  • Other Types
  • 300MG
  • WHO
  • Suitable for all
  • Anti-Cancer
  • Tablets
  • Aged Person, Adults, Teenagers
  • 30 TABLET Container

Trade Information

  • Mundra port
  • Paypal, Telegraphic Transfer (T/T), Cash Advance (CA), Cash Against Delivery (CAD)
  • 5000 Bottle Per Week
  • 15 Days
  • Contact us for information regarding our sample policy
  • CONTAINER
  • Africa, Middle East, Western Europe, Eastern Europe, South America, Australia, Asia
  • All India
  • WHO-GMP

Product Description

Viread 300mg Tablet is not a cure for HIV/AIDS and only helps to decrease the amount of HIV in your body. This helps to lower your risk of getting HIV-related complications and improves your lifespan. It may also be used to prevent HIV infection in some people at high risk. This medicine is best taken with food. It is used in combination with other anti-HIV medicines. Taking these medicines regularly at the right time greatly increases their effectiveness and reduces the chances of HIV becoming resistant to them. It is important not to miss doses and to keep taking them until your doctor tells you it is safe to stop.

USES OF VIREAD TABLET


SYPTONE IMPEX

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



Back to top
SYPTONE IMPEX All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.(Terms of Use)
Developed and Managed by Infocom Network Ltd.